Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

PL EN


Preferences help
enabled [disable] Abstract
Number of results

Journal

2011 | 6 | 5 | 598-601

Article title

Abdominal giant lymph node hyperplasia (Castleman’s disease): report of two cases

Content

Title variants

Languages of publication

EN

Abstracts

EN

Publisher

Journal

Year

Volume

6

Issue

5

Pages

598-601

Physical description

Dates

published
1 - 10 - 2011
online
9 - 8 - 2011

Contributors

author
  • Division of Ultrasound, Liaocheng People’s Hospital and Liaocheng Clinical School of Taishan Medical University, Liaocheng, Shandong, 252000, P. R. China
author
  • Shandong Provincial Medical Imaging Research Institute, Jinan, Shandong, 250012, P. R. China
author
  • School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2678, Australia

References

  • [1] Castleman B., Iverson L., Menedez V.P. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer., 1956, 9, 822–830 http://dx.doi.org/10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4[Crossref]
  • [2] Bhatti M. A.K., Ferrante J.W., Gielchinsky I., Norman J.C. Giant lymph node hyperplasia of the mediastinum (castleman’s disease): case report and review. Tex Heart Inst J., 1984, 11: 378–384
  • [3] Kim J. H., Jun T.G., Sung S.W., Shim Y.S., Han S.K., Kim Y.W., Yoo C.G., Seo J.W., Rho J.R. Giant lymph node hyperplasia (Castleman’s disease) in the chest. Ann Thorac Surg., 1995, 59: 1162–1165 http://dx.doi.org/10.1016/0003-4975(95)00068-V[Crossref]
  • [4] Seirafi P. A., Ferguson E., Edwards F.H. Thoracoscopic resection of Castleman disease: case report and review. Chest., 2003, v123:280–282 http://dx.doi.org/10.1378/chest.123.1.280[Crossref]
  • [5] Bandera B., Ainsworth C., Shikle J., Rupard E., Roach M. Treatment of unicentric castleman disease with neoadjuvant rituximab. Chest., 2010, 138: 1239–1241 http://dx.doi.org/10.1378/chest.09-2084[WoS][Crossref]
  • [6] Rena O., Casadio C., Maggi G. Castleman’s disease: unusual intrathoracic localization Eur J Cardiothorac Surg., 2001, 19, 519–521. http://dx.doi.org/10.1016/S1010-7940(01)00613-3[Crossref]
  • [7] Weisenburger D. D., Nathwani B.N., Winberg C.D., Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol., 1985,16:162–172 http://dx.doi.org/10.1016/S0046-8177(85)80065-4[Crossref]
  • [8] Slotwiner A., Garwacki C.P., Moll S. Castleman’s disease. Am J Hematol., 2003,73:64–65 http://dx.doi.org/10.1002/ajh.10318[Crossref]
  • [9] McAdams H. P., Rosado-de-Christenson M.R., Fishback N.F., Templeton P.A. Castleman disease Of the thorax: radiologic features with clinical and histopatholigic correlation. Radiology., 1998, 209, 221–228
  • [10] Kim M. H., Hwang S., Choi Y.B., Oh S.T., Kim S.C., Choi G.M., Ahn C.S., Kim K.H., Moon D.B., Ha T.Y., Song G.W., Jung D.H., Yu E.S., Lee S.G. Castleman disease of the abdomen-single-center experience of 13 surgically treated patients over 11 years. Hepato-Gastroenterol., 2010, 57, 1060–1063
  • [11] Dispenzieri A., Gertz M.A. Treatment of Castleman’s disease. Curr Treat Options Oncol., 2005, 6, 255–266 http://dx.doi.org/10.1007/s11864-005-0008-z[Crossref]
  • [12] Chronowski G. M., Ha C.S., Wilder R.B., Cabanillas F., Manning J., Cox J.M. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer. 2001, 92, 670. http://dx.doi.org/10.1002/1097-0142(20010801)92:3<670::AID-CNCR1369>3.0.CO;2-Q[Crossref]
  • [13] Powles T., Stebbing J., Bazeos A., Hatzimichael, E., Mandalia, S., Nelson, M., Gazzard, B., Bower, M. The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman’s disease. Ann Oncol., 2009, 20, 775–779 http://dx.doi.org/10.1093/annonc/mdn697[WoS][Crossref]
  • [14] van Rhee F., Fayad L., Voorhees P., Furman R., Lonial S., Borghaei H., Sokol L., Crawford J., Cornfeld M., Qi M., Qin X., Herring J., Casper C., Kurzrock R. Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman’s disease. J Clin Oncol., 2010, 28, 3701–3708 http://dx.doi.org/10.1200/JCO.2009.27.2377[Crossref][WoS]

Document Type

Publication order reference

Identifiers

YADDA identifier

bwmeta1.element.-psjd-doi-10_2478_s11536-011-0067-4
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.